Respiratory Function in Patients With Post-tuberculosis Lung Impairment
Evaluation of Respiratory Function in Patients With Post-tuberculosis Lung Impairment After Pulmonary Tuberculosis Treatment or After Spontaneous Healing
1 other identifier
interventional
100
1 country
1
Brief Summary
Pulmonary tuberculosis (TB) is an important risk factor for chronic respiratory disease due to residual lung damage. A recent review of the literature on TB sequelae and rehabilitation has provided clear evidence that TB is definitively responsible for lung function impairment. Functional evaluation of TB patients after completion of pulmonary tuberculosis treatment or spontaneous healing should be considered as part of clinical care. Unfortunately, few studies are available in the literature investigating the physiopathology of lung damage, its impact on quality of life, the potential need for pulmonary rehabilitation (PR), and the effects of a PR program.Objectives of this prospective multicentre international study are: Primary Objective-to assess the exercise capacity 6-min walking test in patients with post-TB lung impairment after completion of pulmonary tuberculosis treatment or after spontaneous healing. Secondary Objectives-to assess the effects of the PR program on dyspnoea symptoms and muscle fatigue, quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2019
CompletedStudy Start
First participant enrolled
February 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2021
CompletedJanuary 29, 2019
January 1, 2019
1.5 years
January 14, 2019
January 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-min walking test
Exercise capacity
1 year
Secondary Outcomes (4)
dyspnoea
1 year
muscle fatigue
1 year
health related quality of life
1 year
health status
1 year
Study Arms (1)
pulmonary rehabilitation
EXPERIMENTALPulmonary rehabilitation program
Interventions
Pulmonary rehabilitation programme:15 aerobic-training sessions, 15 strength-training sessions for peripheral muscles, 3 face to face and/or Group educational sessions, if needed airways clearance techniques and/or inspiratory muscles training
Eligibility Criteria
You may qualify if:
- \- Patients with post-TB lung impairment after completion of pulmonary tuberculosis treatment - Patients with post- TB impairment after spontaneous healing
You may not qualify if:
- Any unstable medical condition
- Musculoskeletal disorders contraindicating participation in the PR program
- Cognitive impairment (Mini Mental State Examination \<22)
- Unable to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Università degli Studi dell'Insubrialead
- Fondazione Salvatore Maugericollaborator
- Azienda Ospedaliero Universitaria di Sassaricollaborator
- Instituto Nacional de Enfermedades Respiratoriascollaborator
Study Sites (1)
ICS Maugeri, IRCCS
Tradate, Varese, 21049, Italy
Related Publications (2)
Tiberi S, Munoz-Torrico M, Duarte R, Dalcolmo M, D'Ambrosio L, Migliori GB. New drugs and perspectives for new anti-tuberculosis regimens. Pulmonology. 2018 Mar-Apr;24(2):86-98. doi: 10.1016/j.rppnen.2017.10.009. Epub 2018 Feb 24.
PMID: 29487031BACKGROUNDMunoz-Torrico M, Rendon A, Centis R, D'Ambrosio L, Fuentes Z, Torres-Duque C, Mello F, Dalcolmo M, Perez-Padilla R, Spanevello A, Migliori GB. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis? J Bras Pneumol. 2016 Sep-Oct;42(5):374-385. doi: 10.1590/S1806-37562016000000226.
PMID: 27812638RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Giovan Battista Migliori, Prof
ICS Maugeri, IRCCS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 14, 2019
First Posted
January 29, 2019
Study Start
February 14, 2019
Primary Completion
July 31, 2020
Study Completion
January 14, 2021
Last Updated
January 29, 2019
Record last verified: 2019-01